Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
From the launch
reach us at founders@strandai.com Strand AI (YC W26) - multimodal foundation models to predict missing patient biology.
